Two experts highlight noteworthy updates in the transplant and cellular therapy space. Read more.
The Center for Blood and Cancer Disorders in Fort Worth, Texas, is participating in many value-based contracts. Here’s how it is successful.
A new study explored racial/ethnic differences in healthcare outcomes among patients receiving home healthcare. Here are the shocking results.
New treatment approaches could lead to even higher costs associated with lymphoma. However, experts say these treatments hold great promise and could reduce costs in the long-term.
The new Bipartisan Budget Act of 2018 (to be in effect on January 2019) institute new reimbursement guidelines for biosimilars under the Medicare coverage gap discount program that remove disincentives for biosimilar uptake and level the playing field for the future market place.
Congress recently began hearings on proposals to combat opioid abuse. Our policy analyst weighs in.
Here's how artificial intelligence improves the healthcare ecosystem.
Experts say this new migraine medication, the first in 50 years, shows great promise. Here’s what you need to know, including the cost implications
A new survey from Express Scripts has surprisingly findings about medication adherence in patients with chronic diseases.
Two health plans are sharing the wealth—in this case, drug discounts from manufacturers—with consumers at point of sale.